Screening for thoracic aortic pathology: Clinical practice in a single tertiary center by Bons, L.R. (Lidia) et al.
Congenital Heart Disease. 2018;1–9.	 	 wileyonlinelibrary.com/journal/chd	 | 	1.
 
Received:	17	July	2018  |  Revised:	20	July	2018  |  Accepted:	20	July	2018
DOI: 10.1111/chd.12663
O R I G I N A L  A R T I C L E
Screening for thoracic aortic pathology: Clinical practice in a 
single tertiary center
Lidia R. Bons  MD1 | Lucas Uchoa de Assis  BSc1 | Silvy Dekker  MSc1 |  
Robert M. Kauling  MD1 | Judith A.A.E. Cuypers  MD, PhD1 |  
Hence J.M. Verhagen  MD, PhD2 | Ricardo P.J. Budde  MD, PhD3 |  
Jolien W. Roos‐Hesselink  MD, PhD1
1Department	of	Cardiology,	Erasmus	
Medical	Center,	Rotterdam,	The	Netherlands
2Department	of	Vascular	Surgery,	Erasmus	
Medical	Center,	Rotterdam,	The	Netherlands
3Department	of	Radiology	and	Nuclear	
Medicine,	Erasmus	Medical	Center,	
Rotterdam,	The	Netherlands
Correspondence
J.W.	Roos‐Hesselink,	Cardiology,	Erasmus	
MC,	Rg‐435,	Doctor	Molewaterplein	40,	
3015	GD	Rotterdam,	The	Netherlands.
Email:	j.roos@erasmusmc.nl
Funding information
This	study	was	supported	by	the	Dutch	
Heart	Foundation	(contract	grant	number:	
2013T093).
Abstract
Objective:	The	aim	is	to	present	current	clinical	practice	of	thoracic	aorta	screening	in	
a	tertiary	referral	center.	We	identified	how	often	imaging	techniques	were	used	for	
screening	and	established	the	value	of	transthoracic	echocardiography	(TTE)	in	com‐
parison	with	computed	tomography	(CT)	to	detect	aortic	dilation.	We	also	investigated	
which	additional	abnormalities	of	the	heart,	aorta	or	smaller	arteries	were	discovered.
Design:	All	patients	≥15	years	who	visited	our	tertiary	center	in	2012‐2016	for	first	
thoracic	aortic	 screening	were	 retrospectively	 included.	Diameters	of	 the	sinus	of	
Valsalva	(SoV)	and	maximum	ascending	aorta	(AA)	were	compared	between	TTE	and	
CT.	The	sensitivity	and	specificity	of	TTE	to	detect	aortic	dilation	(≥40	mm)	was	as‐
sessed	with	CT	as	reference	standard.	Intracardiac	abnormalities	found	with	TTE	and	
arterial	abnormalities	found	with	CT	were	identified.
Results:	In	total	349	patients	(155	men,	age	41	±	15	years,	10%	genetic	mutation)	were	
included.	Screening	was	performed	with	TTE	only	in	35%	and	with	TTE	and	CT	in	65%.	
Patients	who	underwent	TTE	only	were	younger,	had	less	often	hypertension	and	less	
often	a	family	history	of	aortic	pathology.	Although	there	was	a	good	correlation	be‐
tween	TTE	and	CT,	the	diameters	measured	with	TTE	were	typically	lower	(SoV	−1.0,	
95%CI	−6.6	to	4.7	and	AA	−0.4,	95%CI	−6.5	to	5.8).	Sensitivity	of	TTE	for	detecting	aortic	
dilation	was	61%	(SoV)	and	57%	(AA)	and	specificity	was	96%	(SoV)	and	100%	(AA).	Valve	
abnormalities,	ventricular	dilation	or	reduced	ventricular	function	was	found	with	TTE	in	
26	patients	(7%).	In	47	patients	(13%)	ascending	aortic	dilation	was	diagnosed	and	in	10	
patients	(4%)	relevant	peripheral	arterial	abnormalities	were	identified	using	CT.
Conclusions:	Most	often	patients	received	both	TTE	and	CT	(65%).	Since	TTE	showed	
a	low	sensitivity	to	detect	aortic	dilation,	CT	imaging	is	advised	at	least	once	in	pa‐
tients	referred	for	thoracic	aortic	screening.
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1  | INTRODUC TION
Thoracic	 aortic	 aneurysm	 (TAA)	 is	 typically	 clinically	 silent.	Very	
often	 the	 first	 presentation	 is	 an	 acute	 aortic	 dissection	 or	 rup‐
ture	with	high	rates	of	mortality.1	The	estimated	prevalence	of	a	
TAA	in	the	general	population	is	0.3%,2	but	there	can	be	a	genetic	
predisposition.	Screening	of	patients	at	risk	for	thoracic	aortic	dila‐
tion	(eg,	family	members,	mutation	carriers)	is	important	to	timely	
detect	dilation	and	allow	preventive	intervention	before	dissection	
or	rupture	will	occur.	Persons	who	are	referred	for	screening	can	
undergo	several	possible	imaging	examinations	to	assess	the	tho‐
racic	aorta.	Currently,	transthoracic	echocardiography	(TTE),	com‐
puted	tomography	(CT)	and	magnetic	resonance	imaging	(MRI)	are	
used	 for	diagnostic	 imaging	of	 the	aorta.	TTE	excels	 in	 temporal	
resolution,	 is	harmless,	cheap	and	can	be	used	in	any	clinical	set‐
ting,	but	it	will	not	show	the	entire	thoracic	aorta.	Especially,	the	
upper	 part	 of	 the	 ascending	 aorta	 and	 the	 arch	may	 be	 hard	 to	
visualize.	The	primary	strength	of	CT	is	the	high	spatial	resolution,	
but	the	drawback	is	the	radiation	exposure	and,	for	optimal	visu‐
alization,	need	for	the	use	of	intravenous	iodinated	contrast.	MRI	
falls	between	these	extremes:	it	images	the	entire	thoracic	aorta,	
requires	no	radiation	and	can	be	performed	without	contrast	ad‐
ministration.	 Current	 guidelines3‐5	 advise	 to	 offer	 screening	 to	
first‐degree	relatives	of	patients	with	a	TAA,	especially	in	case	of	
a	bicuspid	aortic	valve	or	Marfan	syndrome.	However,	no	specific	
imaging	modality	is	advised	for	screening	of	the	thoracic	aorta,	in	
contrast	to	the	existing	clear	guidelines	for	screening	for	abdom‐
inal	 aortic	 aneurysms	 which	 favor	 ultrasound.6,7	 The	 American	
Society	of	Echocardiography	(ASE)	and	the	European	Association	
of	Cardiovascular	Imaging	(AECI)4	choose	TTE	as	first	choice,	but	
the	European	Society	of	Cardiology	 (ESC)3	 prefers	 screening	 for	
aneurysms	not	only	in	the	thoracic	aorta,	but	also	throughout	the	
arterial	tree	(including	cerebral	arteries)	with	CT	or	MRI.	The	ques‐
tion	remains	whether	the	more	expensive	and	potentially	harmful	
CT	examinations	should	be	used	and	are	necessary	in	all	patients	
referred	 for	 screening.	 A	 relatively	 new	 concept	which	 is	 enter‐
ing	clinical	care	is	the	“Choosing	wisely”	campaign	initiated	by	the	
American	Board	of	Internal	Medicine	Foundation	(ABIM).	The	goal	
is	to	provide	evidence‐based	care	which	is	free	from	harm	and	truly	
necessary.	 Overuse	 of	 low‐value	 services	 is	 a	 significant	 prob‐
lem.8,9	To	choose	an	appropriate	 imaging	approach	 for	screening	
in	patients	at	risk	for	aortic	pathology,	the	advantages	and	disad‐
vantages	of	each	 imaging	modality	must	be	carefully	considered.	
In	our	center,	we	use	predominantly	CT	and	TTE.	The	exact	value	
of	 these	 examinations	 in	 screening	 for	 TAAs	 is	 not	 well	 known.	
Expected	associated	abnormalities,	both	cardiac	and	 in	 the	great	
arteries,	may	guide	the	choice	of	 imaging	modality.	However,	the	
prevalence	of	associated	cardiac	abnormalities	and	aneurysms	 in	
the	great	vessels	has	not	been	studied	previously.	The	aim	of	this	
study	was	to	describe	current	clinical	practice	of	screening	for	tho‐
racic	aortic	pathology	in	a	tertiary	center.	We	studied	which	imag‐
ing	techniques	were	used	for	screening	and	aimed	to	establish	the	
accuracy	of	TTE	in	comparison	with	CT	to	detect	aortic	dilation	in	
patients	who	underwent	both	examinations.	We	also	investigated	
which	additional	abnormalities	of	the	heart,	aorta,	or	other	great	
vessels	were	discovered.
2  | METHODS
All	 consecutive	 adults	 scheduled	 for	 screening	 of	 thoracic	 aor‐
tic	 disease	 in	 a	 specialized	 tertiary	 cardiology	 outpatient	 clinic	
between	 2012	 and	 2016	 were	 retrospectively	 included	 in	 this	
study.	Patients	are	referred	for	aortic	screening	or	follow‐up	and	
treatment	of	already	existing	 (syndromes	with)	aortic	pathology.	
Patients	underwent	no	previous	imaging	investigations	for	screen‐
ing	of	the	thoracic	aorta	elsewhere.	Inclusion	criteria	for	our	study	
were:	 (1)	 age	 ≥15	years,	 (2)	 first	 visit	 to	 the	 outpatient	 clinic	 of	
thoracic	 aortic	 disease	 and	 (3)	 screening	 as	 reason	 of	 referral.	
The	 decision	which	 imaging	modality	was	 indicated	 for	 patients	
was	 based	on	 clinical	 experience	 and	 preference	 of	 the	 treating	
physician	 (JR,	 JC,	or	RM).	Demographic,	 clinical,	 and	 family	data	
together	with	 information	about	genetic	testing10	were	obtained	
from	 the	 electronic	 patient	 files.	 Hypertension,	 hypercholester‐
olemia,	and	diabetes	mellitus	were	defined	as	current	use	of	med‐
ication	 for	 that	 particular	 disease.	 The	 study	 complied	with	 the	
Declaration	of	Helsinki	and	was	approved	by	the	medical	ethical	
committee	of	the	Erasmus	Medical	Center.	Informed	consent	was	
not	obliged.
2.1 | Aortic diameters
On	CT,	 the	 aortic	 diameters	were	measured	 following	 a	 standard	
protocol	at	the	level	of	the	sinus	of	Valsalva	(SoV),	ascending	aorta,	
aortic	 arch,	 and	 descending	 aorta.	 Both	 the	 ascending	 aorta	 (AA)	
and	descending	aorta	 (DA)	were	measured	at	 the	maximum	diam‐
eter	(mostly	at	the	level	of	the	left	atrium	or	pulmonary	bifurcation).	
On	TTE,	 the	diameters	of	 the	SoV	and	AA	 (largest	diameter)	were	
measured	and	compared	with	CT	measurements.
2.2 | Transthoracic echocardiography
Standard	 two‐dimensional	 TTE	 was	 performed	 by	 experienced	
sonographers,	following	a	standard	protocol.	All	studies	were	ac‐
quired	 using	 harmonic	 imaging	 on	 an	 iE33	 or	 EPIQ7	 ultrasound	
system	(Philips	Medical	Systems,	Best,	The	Netherlands)	equipped	
with	an	×5‐1	matrix‐array	transducer	(composed	of	3040	elements	
operating	 at	 1‐5	MHz).	 The	 aorta	was	measured	 in	 the	 standard	
parasternal	 long‐axis	 view	 and	 acquisition	 of	 the	 long‐axis	 view	
performed	 from	 a	 different	 intercostal	 space	 or	 at	 a	 different	
distances	from	the	sternal	border	to	improve	the	visualization	of	
the	 ascending	 aorta.11	 The	measurements	were	performed	 from	
leading	 edge‐to‐leading	 edge	 during	 diastole.	 The	 presence	 of	 a	
bicuspid	aortic	 valve	was	assessed	on	TTE	and	classified	as	yes,	
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no	or	 unclear.	Aortic	 stenosis	was	 defined	 as	 peak	 aortic	 veloc‐
ity	≥2.5	m/s.	Aortic	regurgitation	was	graded	by	sonographers	as	
mild,	moderate	or	severe	according	to	the	EAE/ASE	guidelines.12 
Septal	wall	thickness	of	≥13	mm	was	identified	as	ventricular	hy‐
pertrophy	and	a	 left	ventricular	diameter	of	≥60	mm	was	 identi‐
fied	as	ventricular	dilation.	The	transthoracic	echocardiogram	was	
analyzed	 using	Curad	off‐line	 software	 (version	3.5.3.0,	Wijk	 bij	
Duurstede,	The	Netherlands).
2.3 | Computed tomography
Contrast‐enhanced	 CT	 scans	 of	 the	 entire	 aorta	 were	 obtained	
with	standard	acquisition	protocols	on	a	variety	of	scanners	includ‐
ing	both	the	thoracic	and	abdominal	aorta	until	the	femoral	artery.	
Overall	 202/226	 (89%)	of	 the	 scans	were	performed	on	 a	 second	
or	 third	 generation	 dual	 source	 scanner	 (Flash,	 Drive	 and	 Force,	
Siemens	 Healthineers,	 Erlangen,	 Germany)	 most	 commonly	 with	
a	high‐pitch	acquisition	 in	183/226	 (81%)	 scans.	For	193/226,	 the	
phase	 of	 the	 RR	 interval	 was	 available	 and	 ranged	 between	 20%	
and	 70%.	 The	 aortic	 diameters	were	measured	 using	 the	 double‐
oblique	technique	perpendicular	to	the	vessel	axis	and	the	SoV	was	
measured	as	 the	cusp‐to‐commissure	distance,	because	 this	 is	 the	
method	most	often	used.4	Arterial	anomalies	were	divided	into	an‐
eurysm,	stenosis,	and	dissection	located	in	the	thorax	or	abdomen.	
We	used	 the	 following	definitions	 for	 clinical	 relevant	 aneurysms:	
aortic	 root	 ≥40	mm,13	 ascending	 and	 descending	 aorta	 ≥40	mm,13 
pulmonary	 artery	 ≥30	mm,14	 abdominal	 aorta	 ≥30	mm,15	 splenic,	
celiac,	 hepatic,	 gastroduodenal,	 pancreaticoduodenal,	 gastric	 or	
mesenteric	arteries	≥20	mm,16,17	iliac	artery	≥25	mm18	and	femoral	
artery	≥20	mm.19	In	addition,	congenital	abnormalities	such	as	a	par‐
tial	anomalous	pulmonary	venous	return	(PAPVR)	were	determined.	
Variants	 in	human	anatomy	 like	aberrant	subclavian	artery	 (lusoria	
artery)	were	also	identified.
2.4 | Statistical methods
All	data	are	presented	as	mean	with	standard	deviation	when	nor‐
mally	distributed,	and	in	case	of	nonnormal	distribution	as	medians	
with	interquartile	ranges.	Data	distribution	was	checked	using	histo‐
grams	and	the	Shapiro‐Wilk	test.	Comparison	of	normally	distributed	
continuous	variables	was	done	using	the	Student’s	t	test	or,	in	case	
of	a	skewed	distribution,	the	Mann‐Whitney	test.	Categorical	vari‐
ables	 are	 presented	 as	 frequencies	with	percentages.	Comparison	
of	 categorical	 variables	was	done	using	 the	 chi‐square	 test	 and	 in	
case	of	an	expected	count	<5	 in	one	of	 the	cells	of	 the	crosstable	
the	Fisher’s	exact	 test	was	used.	Differences	between	 the	diame‐
ter	of	the	aorta	at	TTE	and	CT	were	tested	with	a	paired	t	test	and	
visualized	with	Bland‐Altman	plots.20	The	limits	of	agreement	were	
calculated	using	the	mean	and	standard	deviation	of	the	difference.	
Multivariable	linear	regression	analysis	was	used	to	identify	associa‐
tions	between	aortic	diameter	and	age,	sex	or	aortic	diameter	on	CT	
images.	The	sensitivity	and	specificity	of	TTE	in	diagnosing	an	aortic	
dilation	(≥40	mm)	of	the	SoV	or	AA	was	calculated	with	CT	as	refer‐
ence	method.	The	IBM	SPSS	statistics	21.0	software	(IBM,	Armonk,	
New	York)	was	used	for	data	analysis.	All	statistical	tests	were	two‐
sided	and	a	P	value	below	.05	was	considered	significant.
3  | RESULTS
3.1 | Study population
A	total	of	437	patients	visited	the	outpatient	clinic	of	thoracic	aor‐
tic	disease	for	the	first	time.	Their	age	ranged	from	15	to	82	years.	
In	81%	(354/437)	of	all	patients,	the	indication	was	screening.	The	
other	 patients	 were	 referred	 because	 of	 an	 incidentally	 detected	
aortic	 enlargement	 (n	=	72)	 or	 for	 follow‐up	 of	 aortic	 disease	 dis‐
covered	elsewhere	(n	=	11).	Screening	patients	were	divided	in	two	
groups:	patients	with	only	TTE	and	patients	with	both	TTE	and	CT	in	
our	center.	Due	to	limited	numbers,	patients	who	underwent	only	a	
CT	(n	=	4)	or	MRI	(n	=	1)	were	excluded.
The	349	(44%	male,	mean	age	41	±	15	years)	remaining	patients	
form	the	basis	of	this	study.	They	were	referred	by	the	clinical	genet‐
icist	(67%),	general	practitioner	(24%),	another	specialized	physician	
(7%),	or	an	external	cardiologist	(2%).	The	reasons	for	screening	were	
family	 history	 of	 thoracic	 aortic	 pathology	 in	 208	 patients	 (60%),	
family	history	of	aneurysms	or	dissections	in	other	vessels	than	the	
thoracic	aorta	in	27	patients	(8%),	family	history	of	sudden	cardiac	
death	in	12	patients	(3%),	family	history	with	a	bicuspid	aortic	valve	
in	22	patients	(6%),	suspicion	of	a	syndrome	associated	with	aortic	
pathology	in	60	patients	(17%),	and	a	newly	diagnosed	genetic	muta‐
tion	associated	with	aortic	pathology	in	20	patients	(6%).
Of	 the	 349	 patients,	 123	 (35%)	 patients	 underwent	 only	 TTE	
during	their	visit	and	226	(65%)	patients	underwent	both	TTE	and	CT	
imaging.	 In	four	patients,	CT	 imaging	was	performed	without	con‐
trast.	Of	all	patients	with	CT	imaging,	the	majority	(95%)	underwent	
CT	imaging	of	both	thorax	and	abdomen,	while	12	patients	had	CT	
imaging	of	the	thorax	only.	The	baseline	characteristics	are	shown	
in	Table	1.	In	general,	patients	who	had	TTE	only	were	younger,	had	
lower	 blood	 pressure,	 less	 hypertension	 and	 less	 family	members	
with	an	aortic	aneurysm	or	dissection.	In	108	(31%)	of	the	patients	
genetic	 testing	was	performed,	equally	divided	between	the	2	pa‐
tient	groups.	 In	total,	35	patients	had	a	genetic	mutation	of	which	
most	were	found	in	the	FBN1	gene	(n	=	5),	SMAD3	gene	(n	=	6),	and	
TGFB3	 gene	 (n	=	5).	 These	 genetic	mutations	were	 either	 the	 rea‐
son	 for	 screening	or	 found	 as	 a	 result	 of	 screening.	 In	132	of	 the	
349	 patients	 (38%)	 the	 family	 history	 was	 negative,	 107	 patients	
(31%)	 had	 a	 first‐degree	 or	 second‐degree	 family	 member	 with	 a	
TAA,	57	patients	 (16%)	had	a	first‐degree	or	second‐degree	family	
member	with	a	thoracic	aortic	dissection	and	53	patients	(15%)	had	
both	aneurysm	and	dissection	 in	 their	 family	history.	As	expected	
based	on	guidelines	and	clinical	experience	of	physicians,	patients	
with	a	family	history	of	aortic	aneurysm	or	dissection	underwent	a	
CT	more	often	than	patients	without	such	a	family	history	(69%	vs	
50%,	P	<	.001).
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3.2 | Aortic diameter
In	 total,	 in	 47	 patients	 (13%)	 the	 proximal	 aorta	 (SoV	 or	 AA)	was	
≥40	mm	on	TTE	or	CT	and	in	2	patients	(0.6%)	it	was	≥50	mm.	In	pa‐
tients	who	underwent	both	TTE	and	CT,	the	diameter	of	the	SoV	was	
significantly	 larger	on	CT	compared	 to	TTE	 (33.9	mm	vs	32.9	mm,	
P	<	.001).	However,	the	difference	at	the	level	of	the	AA	was	not	sig‐
nificantly	different	(32.4	mm	vs	32.0	mm,	P	=	.089).	Figure	1	shows	
Bland‐Altman	plots	of	measurements	of	the	aorta	with	TTE	and	CT	
both	at	the	level	of	the	SoV	and	the	AA.	The	diameter	at	the	level	
F I G U R E  1  Bland‐Altman	plots	of	difference	between	echocardiography	and	computer	tomography	at	the	level	of	the	sinus	of	Valsalva	
and	the	ascending	aorta.	Bland‐Altman	plots	comparing	aortic	measurements	performed	using	the	leading‐edge‐to‐leading‐edge	with	echo	
and	inner‐edge‐to‐inner‐edge	with	CT	at	the	level	of	the	sinus	of	Valsalva	(mean	difference	−1.0	mm,	n	=	217)	and	ascending	aorta	(mean	
difference	−0.4	mm,	n	=	221)
TA B L E  1  Baseline	characteristics	screening	patients
Total (n = 349)
Patients with echocardiography 
alone (n = 123)
Patients with echocardiography 
and CT imaging (n = 226) P value
Age	(y) 41	±	15 32	±	12 46	±	15 .000
Female 194	(56%) 71	(58%) 123	(54%) .553
Height	(cm) 176	±	11 178	±	12 175	±	11 .034
Weight	(kg) 77	±	17 73	±	18 79	±	16 .009
Systolic	blood	pressure	(mm	Hg) 130	±	19 125	±	16 133	±	19 .000
Diastolic	blood	pressure	(mm	Hg) 81	±	12 78	±	11 83	±	13 .001
Hypertension 44	(13%) 4	(3%) 40	(18%) .000*
Hypercholesterolemia 7	(2%) 0	(0%) 7	(3%) .055*
Diabetes	mellitus	type	2 7	(2%) 2	(2%) 5	(2%) 1.000*
Beta‐blockers 25	(7%) 5	(4%) 20	(9%) .098
Diuretics 27	(8%) 2	(2%) 25	(11%) .001*
ACE	inhibitors 12	(3%) 0	(0%) 12	(5%) .010*
Values	are	given	in	mean	±SD	or	n	(%).
*Fisher’s	exact	test.	
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of	the	SoV	could	not	be	measured	with	echo	in	one	patient	due	to	
insufficient	 image	quality	 and	with	CT	 in	 four	patients	due	 to	 the	
absence	of	contrast.	The	ascending	aorta	could	not	be	imaged	with	
echo	 in	 nine	 cases	 because	 of	 unfavorable	 aortic	 anatomy	 in	 the	
chest	or	 high	BMI.	At	 SoV	 level,	 the	difference	between	TTE	and	
CT	was	≥5	mm	in	14%	with	a	maximum	difference	of	8	mm,	while	at	
AA	level	a	difference	of	≥5	mm	was	found	in	14%	with	a	maximum	
difference	 of	 11	mm.	With	multiple	 linear	 regression	 analysis,	 age	
was	positively	associated	with	the	difference	 in	diameter	between	
CT	 and	 echocardiography	 for	 both	 the	 level	 of	 the	 SoV	 (P	=	.004)	
and	ascending	aorta	 (P	=	.006).	However,	 for	both	 levels	 the	abso‐
lute	aortic	diameter	was	negatively	associated	with	the	difference	in	
diameter	between	CT	and	echocardiography	(P	<	.001).	This	implies	
that	with	a	smaller	aortic	diameter,	we	are	more	likely	to	find	a	large	
difference	 between	 the	 two	 modalities.	 For	 the	 ascending	 aorta,	
male	gender	was	also	associated	with	a	 larger	difference	between	
the	two	modalities	(P	=	.020).	Sensitivity	of	TTE	for	detecting	aortic	
dilation	was	61%	(SoV)	and	57%	(AA)	and	specificity	was	96%	(SoV)	
and	100%	(AA).
3.3 | Additional findings on echocardiography and 
computed tomography
In	Table	2,	 the	outcomes	of	TTE	and	CT	are	 summarized.	 In	eight	
patients	(2%),	a	BAV	was	found.	Valve	abnormalities	including	BAV	
(5%),	ventricular	hypertrophy	(1%),	and	ventricular	dilation	(1%)	were	
relatively	rare.
In	the	226	patients	who	had	a	CT	scan,	38	arterial	abnormalities	
were	 described	 by	 radiologists	 in	 35	 patients	 (15%)	 in	 addition	 to	
aortic	aneurysms	of	the	SoV	or	AA	(Figure	2).	Twenty‐one	of	these	
arterial	abnormalities	were	found	 in	the	abdomen	(60%).	 Including	
only	clinically	relevant	aneurysms,	we	found	11	abnormalities	in	10	
patients	 (4%	 of	 all	 patients):	 dissection	 of	 the	 renal	 artery	 in	 one	
patient,	 dilation	of	 the	pulmonary	 artery	 (≥30	mm)	 in	 six	 patients,	
dilation	of	the	aortic	arch	in	one	patient,	dilation	of	the	abdominal	
aorta	 (32	mm)	 in	one	patient	and	one	patient	had	a	dilation	of	 the	
femoral	artery	(36	mm)	as	well	as	a	dilation	of	the	abdominal	aorta	
(32	mm).	This	 last	 patient	needed	preventive	 surgery	 for	 the	 fem‐
oral	 artery	 aneurysm.	 Of	 the	 10	 patients	 with	 clinically	 relevant	
peripheral	arterial	abnormalities,	six	patients	also	showed	a	SoV	or	
AA	 of	 ≥40	mm.	 All	 patients	 with	 clinically	 relevant	 abnormalities	
are	shown	in	Table	3.	The	presence	of	an	aneurysm	of	the	proximal	
aorta	was	 associated	with	 vascular	 abnormalities,	 both	 “all	 abnor‐
malities”	(P	=	.004)	and	“clinically	relevant	abnormalities”	(P	=	.013).	
The	presence	of	a	known	genetic	mutation	or	family	history	of	aortic	
disease	was	not	associated	with	vascular	abnormalities	(P	=	.138	and	
P	=	.259,	respectively).
4  | DISCUSSION
In	our	tertiary	center,	the	majority	of	the	patients	referred	for	aortic	
screening	 received	both	TTE	and	CT	 (65%).	 In	our	cohort,	dilation	
(≥40	mm)	of	 the	aortic	 root	or	ascending	aorta	was	 found	 in	13%,	
intracardiac	abnormalities	were	detected	in	7%,	and	relevant	other	
arterial	abnormalities	in	4%.
4.1 | Accuracy of TTE and CT to establish 
aortic dilation
The	 mean	 difference	 of	 the	 proximal	 aortic	 diameter	 measured	
with	 TTE	 vs	 CT	 was	 small,	 but	 large	 differences	 were	 found	 in	
individual	 patients	with	 a	 difference	 of	 up	 to	 8	mm	 for	 the	 SoV	
and	 up	 to	 11	mm	 at	 the	 level	 of	 the	 ascending	 aorta.	 Although	
the	specificity	of	TTE	for	detecting	aortic	dilation	was	good,	the	
sensitivity	was	only	55%‐60%,	which	implies	that	by	imaging	the	
ascending	aorta	in	one	plane	only	on	2DTTE,	the	true	maximal	di‐
ameter	may	easily	be	missed.	This	 is	 in	agreement	with	previous	
literature.21,22	One	previous	study	looked	at	the	ability	of	TTE	to	
TA B L E  2   Imaging	findings	of	echocardiography	and	computed	
tomography	in	screening	patients	(n	=	349)
Echocardiography 
(n = 349)
Computed tomography 
(n = 226)
Bicuspid	aortic	
valve
8	(2%)* ‐
Aortic	stenosis	
(>2.5	m/s)
2	(1%) ‐
Aortic	regurgita‐
tion	(>mild)
2	(1%) ‐
Other	valve	
disease	(>mild)
6	(2%) ‐
Ventricular	
hypertrophy	
(septal	wall	
≥13	mm)
5	(1%) ‐
Ventricular	dilation	
(LV	diameter	
≥60	mm)
4	(1%) ‐
Diameter	sinus	of	
Valsalva	(mm)
32	±	6 33	±	6
Diameter	
ascending	aorta	
(mm)
29	±	8 32	±	5
Diameter	aortic	
arch	(mm)
‐ 26	±	4
Diameter	
descending	aorta	
(mm)
‐ 23	±	4
Any	arterial	
anomaly or 
variant
‐ 35	(16%)
Clinical	relevant	
arterial	anomaly
‐ 10	(4%)
Values	are	given	in	mean	±SD	or	n	(%).
*In	addition	to	this	eight	patients,	we	found	six	patients	with	unclear	aor‐
tic	valve	morphology	because	of	insufficient	image	quality	of	whom	two	
have	a	high	suspicion	of	a	bicuspid	aortic	valve.	
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identify	an	aneurysm	of	the	aortic	root	or	ascending	aorta	in	pa‐
tients	with	a	bicuspid	aortic	valve.23	In	this	paper,	TTE	sensitivity	
to	detect	aortic	dilation	(defined	as	SoV	≥35	mm	and	AA	≥38	mm)	
was	75%	for	the	SoV	and	47%	for	the	AA	with	MRI	as	reference	
standard.	The	authors	concluded	that	TTE	often	misses	aortic	di‐
lation	in	patients	with	a	bicuspid	aortic	valve.	Our	study	confirms	
this	 in	a	more	mixed	population	of	patients	referred	for	thoracic	
aortic	screening.
We	 used	 the	 cusp‐to‐commissure	 method,	 because	 by	 CT	 or	
MRI	the	aortic	root	is	measured	most	often	between	the	inner	edges	
from	commissure	to	opposite	sinus.4	There	 is	still	no	consensus	 in	
the	 guidelines	 how	 to	measure	 the	 aortic	 root	 at	 the	 level	 of	 the	
SoV.	 One	 study	 showed	 that	 the	 cusp‐to‐commissure	 diameter	 is	
best	comparable	with	echocardiography,24	while	others	 show	that	
the	RCC‐NCC	cusp‐to‐cusp	diameter	show	the	best	agreement	with	
echocardiography.25	When	performing	echocardiography	the	exact	
orientation	of	the	measurement	at	the	level	of	the	SoV	relative	to	the	
3	sinuses	highly	depends	on	the	orientation	of	the	echo	probe	during	
the	examination	and	the	orientation	of	the	aortic	root	itself	in	that	
individual.	Therefore,	often	we	don’t	know	if	the	ultrasound	image	
cuts	through	the	cusp	or	commissure	and	this	explains	the	discrep‐
ancies	in	aortic	measurements	between	echo	and	CT.26
In	patients	at	risk	for	thoracic	aortic	pathology,	the	aim	is	to	ac‐
curately	 identify	aortic	dilation	and	therefore	an	accurate	and	reli‐
able	imaging	modality	is	warranted.	In	our	opinion,	CT	or	MRI	meets	
these	requirements	better	than	TTE	and	should	be	used	at	least	once	
for	screening	in	all	patients	at	risk	for	thoracic	aortic	aneurysm	and/
or	dissection.	Particularly	 in	subjects	with	a	more	extended	family	
history	of	aneurysms	or	dissection	in	the	more	distal	thoracic	aorta,	
which	is	not	visible	with	TTE,	advanced	imaging	such	as	CT	or	MRI	
should	be	considered.
4.2 | Should TTE be a part of routine screening?
An	argument	 in	favor	of	using	TTE	as	screening	tool	would	be	the	
ability	 to	detect	 intracardiac	abnormalities,	 including	valve	pathol‐
ogy	and	ventricular	hypertrophy	or	dilation.	In	our	study,	concomi‐
tant	 cardiac	 abnormalities	 were	 rarely	 found	 on	 TTE.	 A	 bicuspid	
aortic	valve	was	present	 in	2%	of	 the	patients,	which	 is	 compara‐
ble	to	the	general	population.27,28	In	our	specific	group	of	patients,	
at	 risk	 for	 thoracic	 aortic	 pathology,	we	 expected	 it	 to	 be	 higher.	
The	prevalence	of	aortic	valve	regurgitation	 in	our	group	was	also	
comparable	to	the	prevalence	found	in	the	Framingham	Heart	Study	
(0%‐2.3%	depending	on	age).29	Aortic	stenosis	was	found	even	less	
often	compared	to	data	from	a	systematic	review	on	aortic	steno‐
sis.30	Other	new	findings	were	not	discovered.	In	our	view,	the	low	
frequency	of	concomitant	 intracardiac	findings	 is	not	a	valid	argu‐
ment	to	choose	TTE	as	a	primary	screening	tool.
4.3 | Additional vascular abnormalities on CT
In	 patients	 referred	 for	 screening	 who	 underwent	 CT,	 we	 found	
peripheral	arterial	pathology	 in	15%,	predominantly	 located	 in	 the	
abdomen.	Eleven	of	these	pathologies	(4%	of	all	patients)	were	clini‐
cally	relevant.	We	showed	that	aneurysms	of	the	SoV	and/or	ascend‐
ing	 aorta	 are	 associated	with	 abnormalities	 in	 other	 intrathoracic,	
F I G U R E  2  Vascular	abnormalities	or	variants	found	with	CT.	Vascular	abnormalities	or	variants	found	in	scanned	area	(gray	rectangle)	
with	CT	while	patients	came	for	thoracic	aortic	pathology	screening.	Thorax	alone	was	scanned	in	12	patients	and	in	214	patients	both	
thorax	and	abdomen	were	scanned.	When	we	only	include	the	clinical	relevant	aneurysms,	we	found	11	abnormalities	(4%	of	all	patients)
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abdominal,	or	more	peripheral	 arteries.	This	 is	well	 known	 for	pa‐
tients	with	SMAD3 or TGFB3	mutation.	 In	patients	with	abdominal	
aortic	aneurysms,	femoral	or	popliteal	aneurysm	are	reported	in	up	
to	14%.31	However,	data	on	the	coexistence	of	peripheral	pathology	
in	the	case	of	TAAs	are	scarce.3	Of	course,	the	clinical	decision	to	
perform	CT	or	not	in	these	patients	implies	a	selection	bias.
4.4 | Which imaging technique in which patient?
Every	patient	referred	for	aortic	screening	should	have	an	accurate	
measurement	 of	 aortic	 dimensions	 by	 CT	 or	 MRI.	 It	 has	 already	
been	shown	that	the	measurement	of	the	thoracic	aortic	diameter	
is	comparable	between	CT	and	MRI.32	Based	on	further	family	his‐
tory	or	specific	genetic	mutation,	an	individual	estimation	should	be	
made	on	 the	 risk	 of	 intracardiac	 or	 peripheral	 vascular	 pathology.	
This	should	guide	the	decision	to	add	TTE	and	choose	between	CT	
and	MRI.	In	our	center,	we	prefer	using	CT	imaging	instead	of	MRI,	
because	the	high	spatial	resolution	allows	simultaneous	imaging	of	
the	smaller	 thoraco‐abdominal	arteries.	Because	connective	tissue	
diseases	like	SMAD333	and	Loeys‐Dietz	are	recognized	increasingly,	
imaging	of	both	aorta	and	peripheral	arteries	is	more	frequently	re‐
quired.	Indeed	in	current	times	the	radiation	dose	is	typically	low	and	
in	our	opinion	 the	 clinical	 relevance	of	 correctly	diagnosing	aortic	
pathology	warrants	optimal	 imaging.	Of	 course	MRI	has	 the	great	
advantage	 of	 not	 exposing	 the	 patient	 to	 radiation	 at	 all	 and	 this	
technique	 should	be	used	 in	 children	when	possible.	The	11	 clini‐
cally	 relevant	arterial	abnormalities	 listed	 in	Table	3	are	 located	 in	
the	larger	arteries	and	would	likely	have	been	picked	up	by	an	MRI	
vasculopathy	study,	which	would	be	an	argument	for	MRI.
In	 patients	 where	 aortic	 dilatation	 is	 diagnosed	 follow‐up	 is	
needed	 to	 identify	 further	growth	of	 the	aorta.	 In	patients	where	
echocardiography	is	able	to	visualize	the	aortic	root	and	ascending	
aorta	 sufficiently,	 echocardiography	 can	 be	 used	 as	 imaging	 tool	
during	follow‐up.	However,	when	TTE	cannot	be	used,	MRI	is	pre‐
ferred,	especially	 in	younger	patients.	Preferably,	follow‐up	should	
be	 performed	with	 the	 same	modality	 using	 the	 same	 technique.	
When	the	aortic	diameter	approaches	the	thresholds	for	preventive	
intervention,	more	accurate	imaging	of	the	aorta	using	CT	(or	MRI)	
is	indicated	to	identify	the	exact	aortic	diameter	and	aortic	anatomy	
before	intervention	is	considered.
In	 conclusion,	 we	 found	 that	 CT	 performs	 better	 than	 TTE	 in	
screening	for	aortic	dilation.	We	advise	to	use	CT	(or	MRI)	for	screen‐
ing	in	all	patients	at	risk	for	thoracic	aortic	disease.	Extra‐aortic	ar‐
terial	abnormalities	were	found	relatively	often	with	CT,	increasing	
the	diagnostic	 value	of	CT	 as	 an	 imaging	 tool.	 Intracardiac	 abnor‐
malities	were	not	common	in	patients	who	were	sent	for	screening	
of	thoracic	aortic	pathology.	Although	TTE	is	a	suboptimal	imaging	
technique	 for	aortic	 screening,	 it	may	be	used	 to	detect	 intra‐car‐
diac	abnormalities	in	selected	cases	such	as	a	family	history	of	BAV.	
For	ongoing	 surveillance	of	patients	with	 aortic	dilatation,	 further	
research	 is	needed	to	determine	the	best	 imaging	strategy	for	on‐
going	surveillance.
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TA B L E  3  Ten	patients	with	a	clinically	relevant	arterial	abnormality	diagnosed	with	CT
Nr Age, gender
Aortic diameters CT (mm)
Genetic 
mutation
Familial 
aneurysm
Familial 
dissection Arterial abnomalitySoV AA Arch DA
1 28,	M 27 24 20 17 COL3a1 0 0 Dissection	renal	artery
2 58,	F 30 30 27 23 No 1 0 Dilation	pulmonary	artery	(32	mm)
3 66,	F 42 43 39 24 No 1 0 Dilation	pulmonary	artery	(45	mm)
4 69,	M 35 34 31 26 SMAD3 0 0 Dilation	pulmonary	artery	(33	mm)
5 48,	M 44 42 30 28 No 1 1 Dilation	pulmonary	artery	(35	mm)
6 60,	M 39 42 27 29 No 1 1 Dilation	pulmonary	artery	(40	mm)
7 75,	F * 48 33 29 No 1 1 Dilation	pulmonary	artery	(41	mm)
8 63,	F 33 38 40 27 No 1 1 Dilation	aortic	arch	(40	mm)
9 62,	M 32 34 28 28 No 0 0 Dilation	abdominal	aorta	(32	mm)
10 62,	M 44 45 39 29 No 1 0 Dilation	femoral	artery	(36	mm)	and	
abdominal	aorta	(32	mm)
Abbreviation:	AA,	ascending	aorta;	DA,	descending	aorta;	SoV,	sinus	of	Valsalva.
*Sinus	of	Valsalva	could	not	be	measured	due	to	non‐enhanced	CT	scan.	
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